EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access

Semaglutide and major adverse cardiovascular events in patients with and without DM: A systematic review and meta‑analysis

Yanhua Li, Chunmei Lv, Lianlian Cao, Sun Lihua, Yanqu Ma

Biomedical Reports · 12.06.2026 · 25 (2) · 1-15

DOI: 10.3892/br.2026.2165 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Biomedical Reports, online erschienen am 12.06.2026. Verfasst von Yanhua Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department of Dongying People's Hospital, Dongying, Shandong 257092, P.R. China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

cardiovascular diseaseglucagon-like peptide-1 receptor agonistmajor adverse cardiovascular eventsmeta-analysissemaglutidetype 2 diabetes

Autor:innen und Institutionen

  • Emergency Department of Dongying People's Hospital, Dongying, Shandong 257092, P.R. China.

Zitieren

APA

Li, Y., Lv, C., Cao, L., Lihua, S., & Ma, Y. (2026). Semaglutide and major adverse cardiovascular events in patients with and without DM: A systematic review and meta‑analysis. Biomedical Reports, 25(2), 1-15. https://doi.org/10.3892/br.2026.2165

Vancouver

Li Y, Lv C, Cao L, Lihua S, Ma Y. Semaglutide and major adverse cardiovascular events in patients with and without DM: A systematic review and meta‑analysis. Biomedical Reports. 2026;25(2):1-15. doi:10.3892/br.2026.2165

BibTeX
@article{Li2026,
  author = {Li, Yanhua and Lv, Chunmei and Cao, Lianlian and Lihua, Sun and Ma, Yanqu},
  title = {Semaglutide and major adverse cardiovascular events in patients with and without DM: A systematic review and meta‑analysis},
  journal = {Biomedical Reports},
  year = {2026},
  volume = {25},
  number = {2},
  pages = {1--15},
  doi = {10.3892/br.2026.2165}
}
Kostenlos starten →